Doi:10.1016/j.jalz.2009.05.027
Alzheimer’s Imaging Consortium IC-P: Poster PresentationsBackground: Rosiglitazone, a peroxisome proliferator-activated receptorcopy. Because of their high iron content, plaques typically appear as hypo-[gamma] (PPAR[gamma]) agonist, has an anti-inflammatory effect in theintense spots on T2-weighted scans. One of the challenges in imagingbrain, decreasing interleukin-1[beta] concentration